Jennifer E. Frank, MD
Department of Family Medicine
School of Medicine and Public Health
University of Wisconsin
Estimated amount of time to complete: 1 hour
THIS PROGRAM WAS ORIGINALLY PRESENTED AS A LIVE PRIMARY CARE WORKSHOP SERIES BEGINNING APRIL 8, 2010. IF YOU RECEIVED CREDIT FOR PARTICIPATING IN ONE OF THE LIVE ACTIVITY, YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ONLINE ACTIVITY.
Female sexual dysfunction (FSD) is a group of disorders affecting over 12 percent of women. FSD may be attributable to a variety of causes. The most common form of FSD is hypoactive sexual desire disorder (HSDD). Women with HSDD experience emotional and psychological distress and significantly diminished sexual and partner relationship satisfaction. However, only one third of women with HSDD seek advice from a healthcare professional.
Primary care clinicians receive little formal training about the topic of sexuality and sexual dysfunction. Therefore, continuing education should focus on how to differentiate among the different sexual dysfunctions, including the common condition of HSDD. Further education will help boost clinician confidence in initiating discussions with women about sexual health. They need education regarding effective ways to have open discussions with their patients so they can effectively diagnose this condition and identify possible interventions.
This program was developed for primary care health care providers.
Upon completion of this educational activity, the participant should be able to:
Differentiate HSDD from other disorders and comorbidities.
Explain how HSDD impacts the quality of life.
Initiate open discussions with patients on the topic of HSDD.
Utilize screening tools to evaluate patients who may be suffering from HSDD.
Employ appropriate interventions in their management of patients with HSDD.
It is the policy of Temple University School of Medicine; The Albert J. Finestone, MD Office for Continuing Medical Education to insure balance, independence, objectivity, and scientific rigor in all of its sponsored or jointly sponsored educational programs. All faculty, program planning committee members, and Temple University School of Medicine Continuing Medical Education staff participating in programs sponsored or jointly sponsored by Temple University School of Medicine are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s).
PLANNING COMMITTEE DISCLOSURE STATEMENT
Planning committee members have no financial relationships to disclose.
FACULTY DISCLOSURE STATEMENT
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, Temple University School of Medicine, Temple University Health System or its affiliates. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Dr Frank has no financial conflicts of interest to disclose.
Accreditation Statement: Temple University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor Continuing Medical Education for physicians.
Certification Statement: Temple University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
There is no fee to participate and receive credit.
Credit Provider Contact Information
School of Medicine
The Albert J. Finestone, M.D.
Office for CME
3500 North Broad Street Philadelphia, PA 19140
Commercial Support Statements
This activity is supported through an educational grant from
Boehringer Ingelheim Pharmaceuticals, Inc. Certificate Fee
Copyright © 2010. Temple University School of Medicine. All rights reserved.
Presented by Temple University School of Medicine and Medical Communications Media, Inc.
The opinions expressed in these educational activities are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Temple University School of Medicine, or Boehringer Ingelheim Pharmaceuticals, Inc. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.
To view our privacy policies, please visit: http://www.cmecorner.com/privacy.asp